FDA recall D-0495-2017

AbbVie Inc. · Class II · drug

Product

Duopa (carbidopa and levodopa enteral suspension), 4.63 mg/20 mg per mL, 100 mL cassette, 7 cassettes per carton, Rx Only, AbbVie Inc., North Chicago, IL 60064 --- NDC 0074-3012-07

Reason for recall

Failed Stability Specifications: confirmed out of specification results obtained during refrigerated material stability testing indicating that drug may settle within drug cassettes nearing the end of their refrigerated shelf-life

Distribution

TN and IL

Key facts

Status
Terminated
Initiation date
2017-01-13
Report date
2017-03-08
Termination date
2019-03-15
Voluntary/Mandated
Voluntary: Firm initiated
Location
North Chicago, IL, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0495-2017